Intercept Pharmaceuticals (ICPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ICPT | CSTL | DSGN | ||
| Company | Intercept Pharmaceuticals | Castle Biosciences Inc | Design Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 19.00 | 28.75 | 12.62 | ||
| High | 19.01 | 30.81 | 13.36 | ||
| Low | 18.98 | 27.50 | 12.06 | ||
| Last | 19.00 | 28.00 | 12.18 | ||
| Change | +0.04 | +1.21 | -0.44 | ||
| Percent Change | +0.21% | +4.52% | -3.49% | ||
| Volume | 3,963,400 | 1,757,800 | 628,200 | ||
| 20-Day Average Volume | 1,984,495 | 401,115 | 614,110 | ||
| Previous | 18.96 | 26.79 | 12.62 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 18.81 | 24.47 | 13.07 | ||
| 20-Day Raw Stochastic | 99.00% | 66.35% | 18.10% | ||
| 20-Day Relative Strength | 74.51 | 67.03 | 46.46 | ||
| Weighted Alpha | -13.30 | +42.76 | +165.24 | ||
| Today's Opinion | 88% Buy | 8% Buy | 40% Buy | ||
| Yesterday's Opinion | 88% Buy | 8% Sell | 72% Buy | ||
| Last Month's Opinion | 56% Buy | 40% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.37% since 10/31/23 | +13.43% since 07/24/26 | +3.40% since 07/24/26 | ||
| Low | 18.93 on 11/02/23 | 23.73 on 07/29/26 | 11.45 on 07/28/26 | ||
| High | 19.02 on 11/06/23 | 30.81 on 07/31/26 | 13.36 on 07/31/26 | ||
| 1-Month | |||||
| %Chg | +2.15% since 10/06/23 | +17.40% since 06/30/26 | -15.83% since 06/30/26 | ||
| Low | 17.01 on 10/13/23 | 22.46 on 07/13/26 | 11.37 on 07/24/26 | ||
| High | 19.02 on 11/06/23 | 30.81 on 07/31/26 | 15.86 on 07/06/26 | ||
| 3-Month | |||||
| %Chg | +82.87% since 08/07/23 | +14.33% since 04/30/26 | -10.44% since 04/30/26 | ||
| Low | 9.70 on 08/14/23 | 17.72 on 05/14/26 | 9.87 on 06/02/26 | ||
| High | 19.02 on 11/06/23 | 30.81 on 07/31/26 | 16.95 on 05/18/26 | ||
| 6-Month | |||||
| %Chg | +17.57% since 05/05/23 | -28.92% since 01/30/26 | +19.29% since 01/30/26 | ||
| Low | 8.82 on 05/24/23 | 17.72 on 05/14/26 | 9.54 on 02/05/26 | ||
| High | 19.02 on 11/06/23 | 40.88 on 02/02/26 | 17.25 on 04/29/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 793,877 | 812,541 | 788,207 | ||
| Shares Outstanding, K | 41,783 | 30,330 | 62,457 | ||
| Annual Sales, $M | 285,710,000 | 344,230,000 | 0 | ||
| Annual Net Income, $M | 221,820,000 | -24,160,000 | -69,790,000 | ||
| Last Qtr Sales, $M | 83,720,000 | 83,680,000 | 0 | ||
| Last Qtr Income, $M | -5,860,000 | -14,520,000 | -17,640,000 | ||
| 60-Month Beta | 0.88 | 1.00 | 1.58 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.07 on 11/06/23 | -0.49 on 05/06/26 | -0.29 on 04/28/26 | ||
| Latest Earnings Date | 03/07/24 | 07/30/26 | 08/06/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||